Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria.
Expanded Malatya criteria
Hepatocellular carcinoma
Liver transplantation
Milan criteria
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
16 Oct 2022
16 Oct 2022
Historique:
received:
05
05
2022
revised:
27
07
2022
accepted:
25
08
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
ppublish
Résumé
Liver transplantation (LT) for hepatocellular carcinoma is still a hot topic, and the main factor that is associated with the success of treatment is to determine the patients who will benefit from LT. Milan criteria have been defined 25 years ago and still is being used for patient selection for LT. However, in living donor LT, the Milan criteria is being extended. Current criteria for patient selection do not only consider morphologic characteristics such as tumor size and number of tumor nodules but also biologic markers that show tumor aggressiveness is also being considered. In the present review article, we have summarized all the criteria and scoring systems regarding LT for hepatocellular carcinoma. All criteria have 5-year overall survival rates that were comparable to the Milan Criteria and ranged between 60%-85%. On the other hand, it was seen that the recurrence rates had increased as the Milan criteria were exceeded; the 5-year recurrence rates ranged between 4.9% to 39.9%. Treatment of hepatocellular carcinoma needs a multidisciplinary approach. Ideal selection criteria are yet to be discovered. The same is true for treatment modalities. The goal will be achieved by a harmonic interplay between basic science researchers and clinicians.
Identifiants
pubmed: 36312504
doi: 10.12998/wjcc.v10.i29.10413
pmc: PMC9602233
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
10413-10427Informations de copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Références
Hepatology. 2009 Mar;49(3):832-8
pubmed: 19152426
Liver Transpl. 2004 Oct;10(10):1301-11
pubmed: 15376305
World J Gastroenterol. 2013 Sep 28;19(36):6077-83
pubmed: 24106409
Drug Discov Ther. 2016;10(4):181-7
pubmed: 27534452
Transplantation. 2020 Jun;104(6):1136-1142
pubmed: 32217938
Ann Surg. 2007 Sep;246(3):502-9; discussion 509-11
pubmed: 17717454
Mol Cancer Ther. 2008 Oct;7(10):3129-40
pubmed: 18852116
Methods Mol Biol. 2015;1238:709-31
pubmed: 25421688
Int J Biol Markers. 2020 Jun;35(2):91-95
pubmed: 32436751
Transplantation. 2003 Feb 15;75(3 Suppl):S37-40
pubmed: 12589138
Liver Transpl. 2003 Nov;9(11):S52-7
pubmed: 14586896
J Investig Med. 2018 Jun;66(5):1-6
pubmed: 29632031
Hepatology. 2001 Jun;33(6):1394-403
pubmed: 11391528
Liver Transpl. 2011 Oct;17 Suppl 2:S133-8
pubmed: 21634006
World J Gastrointest Surg. 2020 Dec 27;12(12):520-533
pubmed: 33437403
Exp Clin Transplant. 2017 Mar;15(Suppl 2):21-24
pubmed: 28301994
Int J Cancer. 2011 Feb 15;128(4):887-96
pubmed: 20473887
Liver Transpl. 2007 Mar;13(3):391-9
pubmed: 17318865
Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5
pubmed: 22750200
Liver Transpl. 2005 Dec;11(12):1505-14
pubmed: 16315294
Oncol Rep. 2012 May;27(5):1303-11
pubmed: 22323095
J Gastrointest Cancer. 2020 Sep;51(3):998-1005
pubmed: 32519232
Transplant Proc. 2014 Apr;46(3):726-9
pubmed: 24767334
Clin Liver Dis (Hoboken). 2019 Feb 21;13(1):20-25
pubmed: 31168361
Gastroenterology. 2018 Jan;154(1):128-139
pubmed: 28989060
Hepatology. 2013 Feb;57(2):637-47
pubmed: 22991213
Surg Oncol. 2020 Jun;33:231-238
pubmed: 31630912
Hepatology. 2016 Dec;64(6):2077-2088
pubmed: 27178646
Transplantation. 2009 Feb 27;87(4):531-7
pubmed: 19307789
J Gastrointest Cancer. 2020 Dec;51(4):1157-1164
pubmed: 32880041
Gastroenterol Hepatol (N Y). 2017 Jul;13(7):398-410
pubmed: 28867968
Ann Surg. 2008 Jun;247(6):1049-57
pubmed: 18520234
J Gastrointest Cancer. 2020 Dec;51(4):1118-1121
pubmed: 32860615
Eur J Clin Invest. 2015 Jun;45(6):609-23
pubmed: 25832714
Liver Transpl. 2008 Jul;14(7):935-45
pubmed: 18581465
Transpl Int. 2021 Mar;34(3):535-545
pubmed: 33449394
J Cancer Res Clin Oncol. 2009 Oct;135(10):1403-12
pubmed: 19381688
JAMA Oncol. 2017 Apr 01;3(4):493-500
pubmed: 27838698
Gastroenterology. 2004 Nov;127(5 Suppl 1):S277-82
pubmed: 15508095
Liver Transpl. 2018 Mar;24(3):369-379
pubmed: 29140601
Dig Dis Sci. 2019 Apr;64(4):993-1000
pubmed: 30895483
World J Gastroenterol. 2014 Jan 14;20(2):333-45
pubmed: 24574704
Ann Surg. 2017 Mar;265(3):557-564
pubmed: 27611615
J Hepatol. 2013 Mar;58(3):609-18
pubmed: 23041304
J Magn Reson Imaging. 2020 Aug;52(2):474-475
pubmed: 32579764
Nat Commun. 2011 Jun 07;2:338
pubmed: 21654638
Liver Transpl. 2007 Dec;13(12):1637-44
pubmed: 18044766
Technol Cancer Res Treat. 2013 Jun;12(3):233-41
pubmed: 23369152
Transplantation. 2000 Apr 15;69(7):1375-9
pubmed: 10798757
HPB (Oxford). 2016 Jul;18(7):593-9
pubmed: 27346140
J Immunol. 2004 Aug 15;173(4):2507-15
pubmed: 15294966
Dig Dis. 2007;25(4):310-2
pubmed: 17960065
Am J Transplant. 2007 Nov;7(11):2587-96
pubmed: 17868066
Transpl Int. 2019 Apr;32(4):356-368
pubmed: 30556935
Liver Cancer. 2018 May;7(2):179-189
pubmed: 29888207
Br J Surg. 1990 Sep;77(9):983-7
pubmed: 2169946
Liver Transpl. 2007 Jun;13(6):896-903
pubmed: 17538994
Transplant Proc. 2018 Mar;50(2):591-594
pubmed: 29579861
Gastroenterology. 2011 May;140(5):1410-26
pubmed: 21406195
Curr Treat Options Oncol. 2020 Mar 19;21(4):31
pubmed: 32193784
J Clin Transl Hepatol. 2020 Mar 28;8(1):69-75
pubmed: 32274347
Surgery. 2013 Nov;154(5):1053-60
pubmed: 24074704
Am J Transplant. 2008 Apr;8(4):839-46
pubmed: 18318783
N Engl J Med. 1996 Mar 14;334(11):693-9
pubmed: 8594428
BMJ. 2017 Apr 11;357:j1806
pubmed: 28400419
Hepatobiliary Pancreat Dis Int. 2007 Jun;6(3):241-7
pubmed: 17548245
World J Gastroenterol. 2018 Aug 28;24(32):3626-3636
pubmed: 30166858
Clin Transplant. 2012 Mar-Apr;26(2):E125-31
pubmed: 22192083
Ann Surg. 1993 Aug;218(2):145-51
pubmed: 8393649
Hepatol Res. 2009 Oct;39(10):979-87
pubmed: 19624768
Liver Transpl. 2008 Oct;14(10):1449-60
pubmed: 18825681
Ann Surg. 2011 Jan;253(1):166-72
pubmed: 21294289
J Hepatol. 2017 Mar;66(3):552-559
pubmed: 27899297
Asian Pac J Cancer Prev. ;18(6):1637-1643
pubmed: 28670882
Lancet. 1999 Nov 6;354(9190):1636-9
pubmed: 10560692
Transplantation. 2008 Jun 27;85(12):1726-32
pubmed: 18580463
Tech Vasc Interv Radiol. 2019 Jun;22(2):70-73
pubmed: 31079713
Liver Transpl. 2003 Jul;9(7):700-2
pubmed: 12827556
J Clin Transl Hepatol. 2018 Mar 28;6(1):69-78
pubmed: 29607307
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
Liver Transpl. 2008 Mar;14(3):272-8
pubmed: 18306328
J Med Assoc Thai. 2010 Nov;93(11):1340-3
pubmed: 21114217
Hepatobiliary Surg Nutr. 2016 Dec;5(6):453-460
pubmed: 28123999
Ann Surg. 2018 Oct;268(4):690-699
pubmed: 30048307
Liver Transpl. 2012 Oct;18(10):1226-36
pubmed: 22685095
Lancet Oncol. 2009 Jan;10(1):35-43
pubmed: 19058754
J Gastrointest Oncol. 2020 Feb;11(1):84-90
pubmed: 32175109
Clin Pract (Lond). 2020;17(3):1497-1505
pubmed: 33343877
J Surg Oncol. 2013 Apr;107(5):544-9
pubmed: 23090720
Semin Intervent Radiol. 2013 Mar;30(1):67-73
pubmed: 24436519
Cancer Sci. 2016 Oct;107(10):1373-1379
pubmed: 27486853
Transplant Proc. 2012 Jul-Aug;44(6):1713-6
pubmed: 22841251
Hepatology. 2002 Mar;35(3):519-24
pubmed: 11870363
Cancer Lett. 2013 Oct 1;339(1):60-9
pubmed: 23879963
J Vasc Interv Radiol. 2015 Aug;26(8):1184-8
pubmed: 26119204
J Hepatocell Carcinoma. 2018 Dec 21;6:1-10
pubmed: 30613572
J Gastrointest Cancer. 2017 Sep;48(3):268-271
pubmed: 28674912
Liver Transpl. 2003 Apr;9(4):425-32
pubmed: 12682897
Semin Liver Dis. 1999;19(3):311-22
pubmed: 10518310
Transplantation. 2018 Aug;102(8):1316-1322
pubmed: 29470357
Updates Surg. 2022 Aug;74(4):1345-1352
pubmed: 34374920
Middle East J Dig Dis. 2013 Oct;5(4):181-92
pubmed: 24829690
Hepatology. 2014 Feb;59(2):567-79
pubmed: 23960017
Exp Clin Transplant. 2021 Dec;19(12):1298-1302
pubmed: 34951348